Skip to main content
TipRanks
Go Ultimate75% OFF

Japan Hospice Holdings Inc. (7061) AI Stock Analysis

0 Followers
JP:7061

Japan Hospice Holdings Inc.

(TSE/TYO:7061)

Select Model
Rating:40Underperform
Price Target:JPY 352.00â–¼(-1.40% Downside)
Action:downgraded
Date:11/19/26

The overall score is critically low, driven primarily by a severe deterioration in financial performance and a deeply bearish technical trend. The company's profitability has collapsed, it is burdened with high debt, and it is burning cash on aggressive investments, creating substantial financial risk. The stock is in a strong downtrend with deeply negative momentum. The high dividend yield offers a potential bright spot but is likely unsustainable given the weak fundamentals.

Positive Factors
Consistent Revenue GrowthSustained revenue expansion indicates that Japan Hospice is continuing to grow its operating base despite weaker profitability. Maintaining top-line momentum can support scale, broaden the reach of its care services, and provide a foundation for margin recovery if cost pressures moderate.
Negative Factors
High LeverageHigh leverage reduces financial flexibility and leaves less capacity to absorb weaker earnings or fund expansion internally. The increase in debt over time also raises the importance of maintaining cash generation, because balance-sheet strain can constrain future investment and capital allocation.

Japan Hospice Holdings Inc. (7061) vs. iShares MSCI Japan ETF (EWJ)

-80%-60%-40%-20%0%20%40%JP:7061-72.15%EWJ+11.78%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 3.05B
Dividend Yield
6.76%
Average Volume (3M)
68.17K
Price to Earnings (P/E)
-29.6
Beta (1Y)
0.90
Revenue Growth
6.75%
EPS Growth
-119.69%
Country
Japan
Employees
1,108
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Japan Hospice Holdings Inc. Business Overview & Revenue Model

Company Description

Japan Hospice Holdings Inc. operates in Japan, focusing on two primary areas: hospice residential care and a range of home-based support services. Its hospice facilities offer specialized care for patients facing terminal cancer and intractable disea...

Japan Hospice Holdings Inc. Financial Statement Overview

Summary

Financial health is severely strained. While revenue has grown, profitability margins have collapsed (net margin fell from 5.3% to 2.0%), net income dropped over 50%, leverage is dangerously high (Debt/EBITDA of 9.2x), and free cash flow is deeply negative (-Â¥1,323M) due to capex being 2.3x operating cash flow. The balance sheet and cash flow scores are critically low, indicating significant solvency and liquidity risks.

Income Statement

30Negative

Balance Sheet

25Negative

Cash Flow

25Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue15.08B14.17B12.12B9.87B7.89B6.02B
Gross Profit2.17B1.84B2.11B1.92B1.58B1.12B
EBITDA1.71B1.43B1.82B1.79B1.40B852.01M
Net Income329.39M278.01M639.58M681.88M454.73M240.80M
Balance Sheet
Total Assets18.75B18.92B18.31B15.16B11.45B9.15B
Cash, Cash Equivalents and Short-Term Investments1.93B2.01B1.53B1.88B1.51B1.04B
Total Debt12.00B13.18B13.19B10.89B8.09B6.67B
Total Liabilities15.09B15.25B14.86B12.47B9.41B7.61B
Stockholders Equity3.66B3.68B3.45B2.69B2.01B1.54B
Cash Flow
Free Cash Flow0-1.32B-2.27B-865.26M340.76M-1.45B
Operating Cash Flow01.05B835.74M1.13B873.83M467.10M
Investing Cash Flow0-511.73M-2.79B-1.01B48.27M-1.98B
Financing Cash Flow0-47.03M1.60B256.45M-448.16M1.59B

Japan Hospice Holdings Inc. Technical Analysis

Technical Analysis SentimentNegative
Last Price357.00

Price Trends

50DMA462.40Negative
100DMA502.24Negative
200DMA641.24Negative

Market Momentum

MACD-21.43Positive
RSI25.69Positive
STOCH4.02Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7061, the sentiment is Negative. The current price of 357.00 is below the 20-day moving average (MA) of 435.95, below the 50-day MA of 462.40, and below the 200-day MA of 641.24, indicating a bearish trend. The MACD of -21.43 indicates Positive momentum. The RSI at 25.69 is Positive, neither overbought nor oversold. The STOCH value of 4.02 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7061.

Japan Hospice Holdings Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:7061 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6062JP:606273OutperformJPY 64.01B14.43―2.19%5.50%45.42%
JP:7071JP:707164NeutralJPY 27.53B8.60―1.43%1.93%-65.20%
JP:2373JP:237357NeutralJPY 5.21B18.02―4.46%4.76%-52.55%
JP:2425JP:242555NeutralJPY 2.50B28.45―3.34%-3.64%-66.52%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:7061JP:706140UnderperformJPY 3.14B-29.57―6.76%6.75%-119.69%

* Healthcare Sector Average

Performance Comparison

-50%0%50%JP:7061JP:2373JP:2425JP:6062JP:7071Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7061 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7061Japan Hospice Holdings Inc.357.00-924.94-72.15%
JP:2373Care Twentyone Corporation385.00-50.94-11.69%
JP:2425Care Service Co., Ltd.658.00-115.78-14.96%
JP:6062Charm Care Corporation1964.00727.3658.82%
JP:7071Amvis Holdings.Inc.282.00-151.57-34.96%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 19, 2026